Elicio Therapeutics, Inc.
ELTX
$10.60
-$0.43-3.90%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -10.56M | -11.21M | -14.00M | -18.84M | -7.23M |
| Total Depreciation and Amortization | 281.00K | 278.00K | 305.00K | 290.00K | 293.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.68M | 1.17M | 1.27M | 9.51M | -3.27M |
| Change in Net Operating Assets | -351.00K | -354.00K | 3.69M | 1.76M | 1.27M |
| Cash from Operations | -8.95M | -10.12M | -8.74M | -7.27M | -8.93M |
| Capital Expenditure | -- | -- | -45.00K | 0.00 | -42.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -45.00K | 0.00 | -42.00K |
| Total Debt Issued | 9.87M | -- | 0.00 | 19.73M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.07M | 10.33M | 227.00K | 11.58M | 316.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -549.00K | -- |
| Cash from Financing | 11.93M | 10.33M | 227.00K | 30.75M | 316.00K |
| Foreign Exchange rate Adjustments | 74.00K | 31.00K | 27.00K | 36.00K | -41.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.06M | 240.00K | -8.54M | 23.52M | -8.70M |